Franchising Rabies Vaccine Delivery in India
Author Information
Author(s): Masum Hassan, Batavia Hima, Bhogal Natasha, Le Kim, Peter A. Singer
Primary Institution: McLaughlin-Rotman Centre for Global Health, University of Toronto
Hypothesis
Can a franchise model effectively deliver affordable rabies vaccines in India?
Conclusion
The franchise model developed by Indian Immunologicals Ltd. has successfully increased the availability and affordability of rabies vaccines in India.
Supporting Evidence
- Over 55,000 people die from rabies each year, with many not receiving vaccines.
- Indian Immunologicals Ltd. has become the largest domestic supplier of rabies vaccine in India.
- The franchise model has expanded to include 3,000 clinics across India.
Takeaway
This study shows that using local doctors to distribute rabies vaccines can help more people get vaccinated and save lives.
Methodology
The study involved semi-structured interviews, site visits, and literature analysis conducted between 2005 and 2009.
Limitations
The health impact of the franchise model is difficult to quantify and requires further research.
Participant Demographics
Participants included physicians, franchisors, and personnel from Indian Immunologicals Ltd.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website